Role of Orexin on Sleep: Interactions with Other Neurotransmitter Systems

Pablo Torterolo,Jaime Monti,S. R. Pandi-Perumal

DOI: https://doi.org/10.1007/978-3-319-23078-8_11

2015-01-01

Abstract:In 1998, a group of phenotypically distinct neurons were discovered in the postero-lateral hypothalamus, which contained the excitatory neuropeptides orexin-A and orexin-B (also called hypocretin-1 and hypocretin-2). Orexinergic neurons project throughout the central nervous system (CNS) and are involved in the generation and maintenance of wakefulness. The sleep disorder narcolepsy, characterized by hypersomnia and cataplexy, is produced by degeneration of these neurons. We conducted a critical review of the literature on the interactions of the orexinergic system with other neurotransmitter systems involved in the generation and maintenance of wakefulness and sleep. Orexin has an excitatory action over the cholinergic, serotonergic, noradrenergic, histaminergic and dopaminergic neurons that constitute the activating system. Moreover, orexinergic neurons modulate the activity of γ-aminobutyric acid (GABA) and melanin-concentrating hormone (MCH) sleep-promoting neurons. Of note, orexin and MCH have opposite postsynaptic effects. In this respect, the orexinergic neurons are active during active wakefulness and “phasic” rapid-eye movement (REM) sleep, while the MCHergic cells are active during non-rapid-eye movement (NREM) sleep and “tonic” REM sleep. We hypothesize that the interactions of these opposite but complementary hypothalamic systems are critical for the generation of either wakefulness or sleep.